Proteome Sciences (LON:PRM) Stock Price Up 16.3% – Time to Buy?

Proteome Sciences plc (LON:PRM) shot up 16.3% during trading on Friday . The stock traded as high as GBX 1.50 and last traded at GBX 1.50. 210,243 shares traded hands during mid-day trading, a decline of 49% from the average session volume of 411,285 shares. The stock had previously closed at GBX 1.29.

Proteome Sciences Trading Up 16.3%

The company has a debt-to-equity ratio of -165.46, a current ratio of 0.13 and a quick ratio of 0.37. The business has a 50 day moving average of GBX 1.64 and a 200 day moving average of GBX 2. The firm has a market capitalization of £5.26 million, a price-to-earnings ratio of -1.33 and a beta of 0.07.

Proteome Sciences (LON:PRM) last announced its quarterly earnings data on Wednesday, April 15th. The company reported GBX (1.04) EPS for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.The company had revenue of GBX 376 million for the quarter.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.